Healthcare News and Research

Latest Healthcare News and Research

Health Canada approves first targeted biological therapy to show survival benefit in stomach cancer

Roche announced today that after priority review, Health Canada has approved HERCEPTIN(R) (trastuzumab), in combination with XELODA(R) (capecitabine) or intravenous 5-fluorouracil and cisplatin, for the first-line treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach (gastric cancer) or gastro-esophageal cancer.

9 Aug 2010

Arcadia Resources first-quarter net revenues decrease to $25.8 million

Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 first quarter net revenues of $25.8 million and a net loss of $4.0 million, or $0.02 per share, which compares to net revenue of $26.4 million and a net loss of $4.6 million, or $0.03 per share for the same period in the fiscal 2010.

9 Aug 2010

Lowell PHO implements MedVentive's technology to manage risk, quality performance

Lowell General Physician-Hospital Organization, a 280-physician integrated delivery system providing outstanding quality care to patients in the Greater Lowell (Massachusetts) area, has implemented MedVentive's award-winning technology platform to manage risk and quality performance. To effectively manage its capitated and incentive-based quality contracts with multiple payers, Lowell PHO sought a comprehensive, flexible technology platform to manage risk, identify improvement opportunities, and proactively outreach to its physicians and patients.

9 Aug 2010

Medical Action Industries first-quarter fiscal 2011 net sales decrease 5.5%

Medical Action Industries Inc., a leading supplier of medical and surgical disposable products, today reported fiscal results for the first quarter ended June 30, 2010.

9 Aug 2010

Millennium Laboratories signs agreement to assist physicians with drug monitoring services, tools

Millennium Laboratories, Inc., a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced today a national agreement with MultiPlan, the nation's leading comprehensive provider of healthcare cost management solutions. As a participating provider in the PHCS and MultiPlan Networks, Millennium Laboratories will assist participating physicians with state-of-the-art therapeutic drug monitoring services and tools.

9 Aug 2010

Chindex first-quarter revenue from Healthcare Services division increases 12.3% to $24.7 million

Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the first quarter of fiscal year 2011, which reflects the three month period ended June 30, 2010.

9 Aug 2010

China-Biotics net sales for first-quarter fiscal 2011 increase 61.8% to $24.9 million

China-Biotics, Inc., a leading developer, manufacturer and distributor of probiotics products in China, today reported its financial results for the first quarter of its 2011 fiscal year, ended June 30, 2010.

9 Aug 2010

RadNet second-quarter revenue increases 6.0% to $139.0 million

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2010.

9 Aug 2010

Remote monitoring of chronic heart failure patients can reduce pressure on resources

Providing patients with chronic heart failure access to remote monitoring, for example by telephone or telemonitoring using wireless technology, reduces deaths and hospitalisations and may provide benefits on health care costs and quality of life. These are the conclusions of a new Cochrane Systematic Review by an international team of researchers.

9 Aug 2010

Mental health debate continues

According to Australian of the Year Professor Patrick McGorry the federal government’s failure to aid mental health resources is a “national obscenity.” He said in an interview, “It's a national obscenity that we're neglecting this issue. We have the solutions in our hands, and we need to put them on deck tomorrow.”

8 Aug 2010

ONA-PCE announces list of endorsed candidates for November General Election

The Ohio Nurses Association's Political Contributing Entity (ONA-PCE) announced today its list of endorsed candidates for the November General Election.

7 Aug 2010

Skilled Healthcare Group files Motion for Mistrial on grounds of juror misconduct

Skilled Healthcare Group, Inc. filed a Motion for Mistrial or New Trial on Grounds of Juror Misconduct with the Superior Court of the State of California, County of Humboldt, earlier today in the case entitled VINNIE LAVENDER, by and through her Conservator, WANDA BAKER, WALTER SIMON; JACQUELYN VILCHINSKY vs. SKILLED HEALTHCARE GROUP, INC., et al (and 22 individually-named California nursing facilities receiving administrative services from Skilled Healthcare, LLC).

7 Aug 2010

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

7 Aug 2010

Myths and realities of Medicare bidding program for durable medical equipment

Providers of home medical equipment and services across California are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage competition, reduce access to care for many of California's 4.6 million Medicare beneficiaries, and put thousands of California homecare providers out of business.

7 Aug 2010

MedQuist contributes to new industry standard measurement policy for transcription jobs

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, continues to support industry best practices for quality standards and metrics. Together with the American Health Information Management Association (AHIMA), the Association for Healthcare Documentation Integrity (AHDI), the Medical Transcription Industry Association (MTIA) and other industry quality leaders, MedQuist contributed to the new Healthcare Documentation Quality Assessment and Management Best Practices just unveiled at the AHDI 32nd Annual Convention and Expo.

7 Aug 2010

Ardea Biosciences second-quarter total revenues decline to $3.5 million

Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.

7 Aug 2010

BMS to join ranks of AIDS drug companies to offer price concessions

Bristol-Myers Squibb will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors, is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key AIDS drug Reyataz.

7 Aug 2010

Halozyme second-quarter revenue increases to $3.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the second quarter ended June 30, 2010.

7 Aug 2010

Northstar Healthcare receives advance from CHA

Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.

7 Aug 2010

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

7 Aug 2010

Healthcare News and Research

Latest Healthcare News and Research

Health Canada approves first targeted biological therapy to show survival benefit in stomach cancer

Arcadia Resources first-quarter net revenues decrease to $25.8 million

Lowell PHO implements MedVentive's technology to manage risk, quality performance

Medical Action Industries first-quarter fiscal 2011 net sales decrease 5.5%

Millennium Laboratories signs agreement to assist physicians with drug monitoring services, tools

Chindex first-quarter revenue from Healthcare Services division increases 12.3% to $24.7 million

China-Biotics net sales for first-quarter fiscal 2011 increase 61.8% to $24.9 million

RadNet second-quarter revenue increases 6.0% to $139.0 million

Remote monitoring of chronic heart failure patients can reduce pressure on resources

Mental health debate continues

ONA-PCE announces list of endorsed candidates for November General Election

Skilled Healthcare Group files Motion for Mistrial on grounds of juror misconduct

Hospital revenue cycle leaders establish protocols for responding to RACs

Myths and realities of Medicare bidding program for durable medical equipment

MedQuist contributes to new industry standard measurement policy for transcription jobs

Ardea Biosciences second-quarter total revenues decline to $3.5 million

BMS to join ranks of AIDS drug companies to offer price concessions

Halozyme second-quarter revenue increases to $3.2 million

Northstar Healthcare receives advance from CHA

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in